Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study
Sakellaris G
Published in Acta Paediatrica
Methodology
Open-label randomised pilot in children/adolescents with TBI given oral creatine 0.4 g/kg daily for 6 months versus no supplement, with monthly assessment of headache, dizziness, fatigue and other post-traumatic symptoms.
Key Findings
In 39 children and adolescents with traumatic brain injury, oral creatine 0.4 g/kg daily for six months reduced the incidence and duration of post-traumatic headache, dizziness and fatigue compared with controls, with fatigue and dizziness essentially abolished in the creatine group over follow-up.
Conclusions
Creatine administration after paediatric traumatic brain injury reduced common post-concussive symptoms in a small open pilot, a striking result that needs blinded replication.
Limitations
Small, non-blinded pilot with control group not receiving placebo, symptom endpoints reported by children and parents, single centre, and no biochemical or imaging confirmation of mechanism.
Supplements Studied
Significant improvement was recorded in the categories of headache (p<0.001), dizziness (p=0.005) and fatigue (p<0.001).
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Institutional/hospital funding
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.